Literature DB >> 25945688

High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.

H ElZomor1,2, H Taha3,2, A Aleieldin4,5, R Nour6, M S Zaghloul7,2, M Fawzi1,2, A Kamel1,2, A S Alfaar4,8,9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25945688     DOI： 10.3109/13816810.2015.1016241

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN： 1381-6810            Impact factor:   1.803


× No keyword cloud information.
  4 in total

1.  An international survey of classification and treatment choices for group D retinoblastoma.

Authors:  Christina Scelfo; Jasmine H Francis; Vikas Khetan; Thomas Jenkins; Brian Marr; David H Abramson; Carol L Shields; Jacob Pe'er; Francis Munier; Jesse Berry; J William Harbour; Andrey Yarovoy; Evandro Lucena; Timothy G Murray; Pooja Bhagia; Evelyn Paysse; Samuray Tuncer; Guillermo L Chantada; Annette C Moll; Tatiana Ushakova; David A Plager; Islamov Ziyovuddin; Carlos A Leal; Miguel A Materin; Xun-Da Ji; Jose W Cursino; Rodrigo Polania; Hayyam Kiratli; Charlotta All-Ericsson; Rejin Kebudi; Santosh G Honavar; Vicktoria Vishnevskia-Dai; Sidnel Epelman; Anthony B Daniels; Jeanie D Ling; Fousseyni Traore; Marco A Ramirez-Ortiz
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

2.  High-Risk Histopathologic Features of Retinoblastoma Treated at a Tertiary Hospital in West Java, Indonesia.

Authors:  Nur Melani Sari; Regina Hadiputri; Maya Sari Kuntorini; Hasrayati Agustina; Friska Mardianty
Journal:  Ocul Oncol Pathol       Date:  2021-07-20

Review 3.  Precise long non-coding RNA modulation in visual maintenance and impairment.

Authors:  Peixing Wan; Wenru Su; Yehong Zhuo
Journal:  J Med Genet       Date:  2016-12-21       Impact factor: 6.318

4.  Orbital relapse of retinoblastoma in patients with high-risk histopathology features.

Authors:  Maria Vittoria Cicinelli; Swathi Kaliki
Journal:  Ther Adv Ophthalmol       Date:  2019-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.